Hanmi Science – World Class Benchmarking
Company: Hanmi Science Company Limited
Bloomberg ticker: 008930 KS
Market cap: US$1,765m
Background: Hanmi Science Company Limited is a Korean holding company for the Hanmi Pharmaceutical Group. The business is focused on healthcare, specifically pharmaceutical R&D, manufacturing, and distribution. It is known for its innovative drugs in metabolic diseases (such as diabetes/obesity), oncology, and rare diseases. Korea and China are its largest markets.
World Class Benchmarking of Hanmi Science
- Profitable Growth rank of 6 was up compared to the prior period’s 8th rank.
- This is below average performance compared to 370 large Health Care companies worldwide.
- Profitability rank of 5 was better than its Growth rank of 8.
- Profitability rank of 5 was up compared to the prior period’s 6th rank.
- This is average performance compared to peers.
- Growth rank of 8 was up compared to the prior period’s 9th rank.
- This is below average performance compared to peers
DISCLAIMER: This content is for information purposes only. It is not intended to be investment advice. Readers should not consider statements made by the author(s) as formal recommendations and should consult their financial advisor before making any investment decisions. While the information provided is believed to be accurate, it may include errors or inaccuracies. The author(s) cannot be held liable for any actions taken as a result of reading this article.